Search

everythinglearnresearchcommunity

for

Search:↓

The scalp fat tissue of men with hair loss shows changes in gene activity that may contribute to their condition.

Surgical hair restoration has improved since 1959, with new techniques like minigrafts, micrografts, and scalp reductions creating more natural hairlines and reducing bald skin, despite some risks and potential for scarring.

Combining scalp reduction and hair transplants improves coverage and appearance for male baldness.

Early exposure to germs may protect against autoimmune diseases, lack of sex increases alcohol preference in fruit flies, a potential baldness treatment could involve blocking a specific receptor, skin memory cells help prevent re-infection, high-fat diets can affect brain cells related to weight, and the link between social status, stress, and heart disease in primates is unclear.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

The new technique PÂTÉ improved the amount of scalp tissue removed in surgeries.

Micrografts improve hair density and thickness without side effects.

Tissue expanders effectively repair large scalp defects and restore a natural-looking scalp.

PGD2 stops hair growth and is higher in bald men with AGA.

New techniques in scalp reconstruction have improved cosmetic results and reduced complications, especially for large defects.

SFRP2 and PTGDS may be key factors in female hair loss.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

A substance called DKK-1 increases in balding areas and causes hair cells to die when exposed to DHT.

The study suggests that a specific gene variation and higher gene activity are linked to increased baldness in Egyptian men.

In 1981, the punch graft technique was the main method for hair transplantation, and medical treatments for baldness were not very effective.

Stem cells show promise for hair loss treatment, but no effective product for hair regeneration has been developed yet.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

ECM changes may play a role in hair loss, with differences between males and females.

The LncRNA AC010789.1 slows down hair loss by promoting hair follicle growth and interacting with miR-21 and the Wnt/β-catenin pathway.

Using human fat tissue derived stem cells in micrografts can safely and effectively increase hair density in people with hair loss.

Finasteride reduces scalp DHT levels, potentially treating male pattern baldness.

Michael L. Beehner proposed a standardized naming system for balding scalp areas to help hair restoration surgery.

Hair from balding and non-balding areas regrows similarly on mice.

Androgen receptors found in monkey scalps, similar to humans, affect hair growth.

The study found that two enzymes linked to hair loss are located in different parts of the scalp, supporting a common treatment's effectiveness.

Michael L. Beehner proposed a standardized way to describe balding areas on the scalp to help hair restoration experts communicate better.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

A man with baldness had successful hair growth after transplanting body hair to his head.